drugset / Trial / NCT03543917
Post-Stroke Improvement of Motor Function
NaSingle-groupOpen-labelTreatment
Summary
Open-label clinical study where all new patients presenting with cerebrovascular accidents and consenting to treatment are given intravenously a new combination of medications. Patients are evaluated neurologically with NIHSS scores before treatment administration and at 1 month after the first treatment. Further evaluations at 6 months after treatment by NIHSS and Barthel scores are ongoing
Timeline
- Start
- 2017-08-08
- Primary completion
- 2018-08-30
- Completion
- 2018-09-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Actovegin | Protein / enzyme biologic | — | Intravenous |
| Background | Dexamethasone | Small molecule | — | Intravenous |
| Background | Oxytocin | Peptide | — | Intravenous |
| Background | Vitamins C | Unknown | — | Intravenous |
| Background | calcium gluconate | Small molecule | — | Intravenous |
| Background | vitamins B1 | Unknown | — | Intravenous |
| Background | vitamins B12 | Unknown | — | Intravenous |
| Background | vitamins B6 | Unknown | — | Intravenous |